Category: Health & Medicines > Medicines > Alogliptin
Country/Region: China State/Province: Hubei
Main Products: Paclitaxel
Business Type: Wholesaler, Retailer
Year Established: 2008
Employees: 5 - 10 People
Plant Area: Below 1,000 square meters
Main Markets: South America 12% Africa 9% Eastern Asia 12% Domestic Market 10% North America 11% Eastern Europe 9% Southern Europe 8% Mid East 8% Northern Europe 11% Oceania 10%
Trade Capacity: FOB, EXW, DEQ
Contract Manufacturing: OEM Service Offered Design Service Offered
Nearest Port: Wuhan
Annual Revenue: US$10 Million - US$50 Million
Total Revenue: US$5 Million - US$10 Million
Export Revenue: US$2.5 Million - US$5 Million
Annual Output: US$2.5 Million - US$5 Million
Registered Capital: confidential
Export Percentage: 71% - 80%
Payment Modes: USD, AUD, HKD
Lead Time: 17 days
Import/Export Mode: Using an agent